effective risk communication on covid19 vaccination in Malaysia

Introduction

Effective risk communication is crucial for the success of COVID-19 vaccination programs. In Malaysia, understanding the factors influencing vaccine acceptance and addressing concerns among the population are key to achieving high vaccination rates and controlling the pandemic.

Key Insights

Vaccine Effectiveness:
- Full vaccination with AZD1222, BNT162b2, and CoronaVac has been highly effective in preventing COVID-19 infection, symptomatic COVID-19, ICU admissions, and deaths .
Vaccine Acceptance:
- High overall acceptance rate of COVID-19 vaccines among Malaysians, with 83.3% to 93.2% willing to get vaccinated if offered for free .
- Acceptance is lower among the elderly and those with certain medical conditions like diabetes and hypercholesterolemia.
Concerns and Hesitancy:
- Main concerns include side effects, safety, lack of information, and effectiveness of the vaccines.
- Predictors of vaccine hesitancy include age, religion, and current residence.
- High perceived risk and severity of COVID-19 are associated with higher willingness to be vaccinated.
Communication Strategies:
- Social media is the primary source of information about COVID-19 for most Malaysians.
- Public health strategies should focus on addressing perceived risks, susceptibility, and vaccine hesitancy to enhance vaccine uptake.

Conclusion

In Malaysia, effective risk communication for COVID-19 vaccination should focus on highlighting the high effectiveness of the vaccines, addressing concerns about side effects and safety, and targeting specific groups with lower acceptance rates. Utilizing social media for information dissemination and tailoring public health strategies to address perceived risks and hesitancy can significantly improve vaccine uptake.

Effective risk communication on covid19 vaccination in Malaysia

Summary

Introduction

Key Insights

Conclusion

Sources and full results

PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

Full vaccination with any of the three predominant COVID-19 vaccines (AZD1222, BNT162b2, and CoronaVac) in Malaysia has been highly effective in preventing COVID-19 infection, symptomatic COVID-19, COVID-19-related ICU admission, and death.

COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence

Early evidence suggests that COVID-19 vaccines, particularly AZD1222, BNT162b2, and CoronaVac, have been highly effective in preventing infections, ICU admissions, and death in Malaysia.

A survey on COVID-19 vaccine acceptance and concern among Malaysians

High acceptance of COVID-19 vaccine among Malaysians (83.3%), but addressing concerns among hesitant individuals is crucial for successful mass immunisation campaigns.

Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey

Malaysians are more likely to accept the COVID-19 vaccine if it is offered for free by the government, and strategies targeting perceived risk, susceptibility, and vaccine hesitancy could enhance vaccine uptake.

Sustaining effective COVID-19 control in Malaysia through large-scale vaccination

Large-scale vaccination in Malaysia can effectively control the COVID-19 epidemic, but micro-distancing, mobility restrictions, and accelerating vaccination are crucial for future control.

When do persuasive messages on vaccine safety steer COVID-19 vaccine acceptance and recommendations? Behavioural insights from a randomised controlled experiment in Malaysia

Persuasive messages on vaccine safety can improve recommendations for people with pre-existing health conditions, but may not significantly impact healthy adults and the elderly.

Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey

Malaysians have inadequate knowledge about COVID-19 vaccines, but 64.5% are willing to get vaccinated, with higher knowledge scores associated with higher education, income, and living with those at higher risk.

COVID-19 vaccination for children in Malaysia - A position statement by the College of Paediatrics, Academy of Medicine of Malaysia.

COVID-19 vaccination is effective and safe for children aged 5-11 years, supporting the College's recommendation for a national vaccination programme in Malaysia.

COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response

Malaysia's COVID-19 response has been successful, with early preparedness, public health systems, and a strict enhanced Movement Control Order reducing fatalities.

COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter?

In Malaysia, age, gender, and vaccine type influence vaccine-related side effects, with the Sinovac vaccine showing a lower risk and fewer side effects than other vaccines.

Try another search